Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ADD. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Mo/Cu-catalyzed method enables mild-condition production of high-purity triazole intermediates with enhanced scalability and supply chain reliability for pharma manufacturers.
Patent CN113735778B enables high-purity pharmaceutical intermediate production through simplified catalytic process enhancing supply chain reliability and reducing manufacturing costs.
Patent CN116253692A enables metal-free trifluoromethyl-triazine production at ambient conditions, ensuring supply chain resilience and cost reduction for high-value pharma intermediates.
Novel silver oxide-promoted synthesis enables high-purity 5-trifluoromethyl imidazole intermediates with enhanced scalability and cost reduction for pharmaceutical manufacturing.
Patent CN113735778B enables efficient production of high-purity trifluoromethyl imidazoles through streamlined silver oxide-promoted cycloaddition, delivering enhanced supply chain resilience and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN107513056A enables metal-free quinoline synthesis with high atom economy enhancing supply chain reliability cost reduction in pharmaceutical manufacturing
Breakthrough asymmetric cycloaddition method enables high-purity chiral heteronucleoside production with enhanced supply chain reliability and cost reduction potential.
Breakthrough Pd-catalyzed asymmetric cycloaddition method achieves up to 95% ee in chiral heteronucleoside synthesis with enhanced supply chain reliability and cost reduction potential.
Patent CN113307778A enables cost-effective manufacturing of high-purity trifluoromethyl triazoles through mild reaction conditions and scalable process design with significant supply chain reliability improvements.
Patent CN113735778B introduces a high-efficiency method for synthesizing trifluoromethyl imidazoles with significant cost reduction and enhanced supply chain reliability in pharmaceutical manufacturing.
Novel stereoselective synthesis method for trans-cyclopropane dicarboxylates achieves near-zero cis-isomer formation, enabling reliable supply chain and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113735778B enables high-purity API intermediates through efficient silver-catalyzed synthesis with enhanced supply chain reliability and scalability.
Novel asymmetric synthesis method enables high-purity chiral spiro pyrrolidine oxindole intermediates with simplified process and enhanced supply chain reliability for pharmaceutical applications.
Metal-free synthesis of trifluoromethyl triazine compounds enables high-purity API intermediates with scalable manufacturing and reduced lead time for pharmaceutical applications.
Novel silver oxide-promoted synthesis enables high-purity 5-trifluoromethyl imidazoles with cost-effective scale-up and reliable supply for pharmaceutical applications.
Novel silver oxide-promoted synthesis achieves high-purity 5-trifluoromethyl imidazoles with simplified process, reducing lead time and manufacturing costs for pharmaceutical intermediates.
Patent CN113735778B enables high-purity imidazole intermediates through simplified process with cost reduction in pharmaceutical manufacturing.
Patent CN113735778B enables high-purity trifluoromethyl imidazoles through scalable silver-promoted cycloaddition, reducing costs and lead times for pharmaceutical intermediates.
Patent CN113735778B enables efficient production of high-purity API intermediates with simplified process, reducing lead time and manufacturing costs for pharmaceutical supply chains.
Patent CN111592507A enables rapid high-yield furan synthesis with mild conditions reducing manufacturing costs and lead times for pharmaceutical intermediates.